Atlas Trials

A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers

Clinical trial NCT01243307 · COMPLETED

Trial details

NCT number
NCT01243307
Sponsor
Creabilis SA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuropathic Pain
Start date
2011-01-01
Primary completion
2011-04-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.